Companies / New York / iBio

· rebuilt nightly from public records

Signal Sheet

Selling to iBio? Who to reach and why now

New York, New York is home to iBio, a publicly listed pharmaceutical preparations company. It raised $26M in Jan 2026 and its filings name 10 officers. Everything below links to the record it came from.

Listed company · Pharmaceutical Preparations · New York

The easy button for new customers

Lakewave's AI keeps accounts like this one coming. Your pipeline refills while you sleep.

Every night it scans funding, filings, new officers, hiring, contracts, permits and bids, finds the accounts that fit what you sell, and delivers each with outreach and a pursuit plan. Just need a list? Its AI waterfall builds one with verified, reachable contacts.

SourceNew accounts that match what you offer, added as the signals land. The list never runs dry.
Reach outA first email written from why the account is hot, then a drip sequence that follows up until they reply. Sent from your own mailbox, with every open and reply tracked.
PursueAn AI-written plan built from your value proposition and the customer's compelling event: who to call, what to lead with, and the next step to win it. In early access.
Start your free trial →Tell it what you sell and where. Your list stays yours.

Who to reach

The roles that matter for a seller right now. Names on this page come from SEC filings or the company's own announcements. Contacts you find with a free trial are verified before you see them. How we source names

RoleContactSourceWhy they matter now
Executive OfficerMartin A. BrennerSEC filing, Jan 2026Named officer in the filing; part of the buying group
Executive OfficerFelipe DuranSEC filing, Jan 2026Named officer in the filing; part of the buying group
Executive OfficerMarc BanjakSEC filing, Jan 2026Named officer in the filing; part of the buying group
Chief Technology OfficerEvert ShimmelpenninkSEC filing, Jan 2026Technology and tooling decisions
Chief Technology OfficerAlexandra KropotovaSEC filing, Jan 2026Technology and tooling decisions
Chief Technology OfficerWilliam ClarkSEC filing, Jan 2026Technology and tooling decisions
Chief Technology OfficerGary SenderSEC filing, Jan 2026Technology and tooling decisions
Chief Technology OfficerDavid ArkowitzSEC filing, Jan 2026Technology and tooling decisions
Chief Technology OfficerAntonio ParadaSEC filing, Jan 2026Technology and tooling decisions
Chief Technology OfficerAlexandra KroptovaSEC filing, Apr 2025Technology and tooling decisions
For sellersWhy iBio is worth a call this quarterBuy Window: open · new leadership Oct 2026
Oct 14Oct 2026

New leadership

Officer or director change

New leadership
$26M

Raised

Equity raise reported to the SEC, Jan 2026. Money arrives before the spending plan does.

Capital
$37.1M9 months

Back-to-back raises

2 equity raises in 9 months. Repeat funding is a company buying for growth, not maintenance.

Pattern
Track iBio with a free trial →Get the next signal the day it is filed or posted.
Email me the next iBio signalOne email when it files, raises, hires or posts a role. Watch up to 3 companies free, no password.

Why now

The most recent events first, refreshed every night. Each links to the record it came from.

WhenWhat happenedKindSource
Oct 14, 2026Officer or director changeNew leadershipSEC filing
Jul 31, 2026Officer or director changeNew leadershipSEC filing
Jan 8, 2026Raised $26M in equity from 7 investorsCapitalSEC filing
Apr 29, 2025Raised $11.1M in equity from 5 investorsCapitalSEC filing

Reach iBio with emails that land

Lakewave finds the right people at iBio, checks every address against the mail server before you see it, and drafts a first email for each, which you review and send from your own inbox.

Try it on iBio with a free trial →

About iBio

HeadquartersNew York, New York, per the filing address
Industry groupPharmaceutical Preparations
OwnershipListed company
Raise history$11.1M (Apr 2025) · $26M (Jan 2026)
Lakewave Rising11 · 2 kinds of evidence · rank in New York after sign-up

Similar companies

Private-sector companies in the same industry group and state, ranked by Rising score.

Acurx Pharmaceuticals · 55Pfizer · 16Regeneron Pharmaceuticals · 5Royalty PharmaIndaptus TherapeuticsProPhase LabsSee all 6 with a free trial →

Questions people ask

Did iBio raise funding in 2026?

Yes. iBio reported a $26M equity raise to the SEC on Jan 8, 2026 with 7 investors.

Who runs iBio?

The company's SEC filing, Jan 2026 names Martin A. Brenner (Executive Officer) among its officers.

Where is iBio headquartered?

New York, New York, per the address on its SEC filing.

Know who is buying before the first callStart your free trial →

Know who is buying before the first call

Select the accounts and territory you sell to and get dated reasons for every company: new budget, new leaders, new hires, with who to reach and a first draft for each contact.

Start your free trial

Compiled from public records and refreshed nightly; last updated Nov 16, 2026. Facts are as the SEC, the company's careers page or the company's own announcements published them. Check the source before acting. See something wrong? Tell us and we will correct it.